These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4629207)

  • 21. RhinoVax is an efficient adjuvant in oral immunisation of young chickens and cholera toxin B is an effective oral primer in subcutaneous immunisation with Freund's incomplete adjuvant.
    Mayo SL; Tufvesson M; Carlsson HE; Royo F; Gizurarson S; Hau J
    In Vivo; 2005; 19(2):375-82. PubMed ID: 15796200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CTL reactivity in the spleen and draining lymph nodes after immunization with peptides pulsed on dendritic cells or mixed with Freund's incomplete adjuvant.
    Wang MJ; Nissen MH; Buus S; Röpke C; Claësson MH
    Immunol Lett; 2003 Nov; 90(1):13-8. PubMed ID: 14611902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination against ergot alkaloids and the effect of endophyte-infected fescue seed-based diets on rabbits.
    Filipov NM; Thompson FN; Hill NS; Dawe DL; Stuedemann JA; Price JC; Smith CK
    J Anim Sci; 1998 Sep; 76(9):2456-63. PubMed ID: 9781501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterial substitutes in "complete" Freund's adjuvant. Effect on antibody production and delayed hypersensitivity to bovine serum albumin.
    Salvaggio JE; Castro-Murillo E
    J Immunol; 1968 Jun; 100(6):1340-52. PubMed ID: 4972188
    [No Abstract]   [Full Text] [Related]  

  • 25. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.
    Wedlock DN; Keen DL; McCarthy AR; Andersen P; Buddle BM
    Vet Immunol Immunopathol; 2002 May; 86(1-2):79-88. PubMed ID: 11943331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between sedimentation value and immunogenic acitivity of mycobacterial ribonucleic acid.
    Youmans AS; Youmans GP
    J Immunol; 1973 Feb; 110(2):581-6. PubMed ID: 4630648
    [No Abstract]   [Full Text] [Related]  

  • 28. EFFECT OF MITOCHONDRIAL STABILIZERS ON THE IMMUNOGENICITY OF THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.
    YOUMANS AS; YOUMANS GP
    J Bacteriol; 1964 Jun; 87(6):1346-54. PubMed ID: 14188712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of protection afforded by ribonucleic acid preparations from Mycobacterium tuberculosis against Mycobacterium leprae infections in mice.
    Shepard CC; Youmans AY; Youmans GP
    Infect Immun; 1977 Mar; 15(3):733-6. PubMed ID: 404242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
    Hovav AH; Bercovier H
    Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INFLUENCE OF BACTERIAL RIBONUCLEIC ACID ON ANIMAL CELLS IN CULTURE. II. PROTAMINE ENHANCEMENT OF RNA UPTAKE.
    AMOS H; KEARNS KE
    Exp Cell Res; 1963 Oct; 32():14-25. PubMed ID: 14094022
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of diethylaminoethyl-dextran (DEAE-D) as adjuvant for immunization of guinea pigs with inactivated foot-and-mouth disease (FMD) virus].
    Wittmann G
    Zentralbl Bakteriol Orig; 1970; 213(1):1-8. PubMed ID: 4318268
    [No Abstract]   [Full Text] [Related]  

  • 33. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.
    Coppel S; Youmans GP
    J Bacteriol; 1969 Jan; 97(1):114-20. PubMed ID: 4974383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoreactivity of mycobacterial 70 kDa protein in different physico-chemical forms.
    Verma I; Yadav D; Sharma S; Sinha R; Khuller GK
    Indian J Med Res; 1997 Jul; 106():13-5. PubMed ID: 9248209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of sensitization protocols on arthritic responses in antigen-induced arthritis.
    Staite ND; Cutshaw LG; Dunn CJ
    Agents Actions; 1989 Jun; 27(3-4):338-40. PubMed ID: 2801320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice.
    Lima KM; Bonato VL; Faccioli LH; Brandão IT; dos Santos SA; Coelho-Castelo AA; Leão SC; Silva CL
    Vaccine; 2001 May; 19(25-26):3518-25. PubMed ID: 11348719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A recombinant truncated surface immunogenic protein (tSip) plus adjuvant FIA confers active protection against Group B streptococcus infection in tilapia.
    He Y; Wang KY; Xiao D; Chen DF; Huang L; Liu T; Wang J; Geng Y; Wang EL; Yang Q
    Vaccine; 2014 Dec; 32(51):7025-7032. PubMed ID: 25446833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunobiological studies with mycobacterial ribonucleic acid-protein complex: Part II--Mechanism of protective immunity against experimental tuberculosis.
    Pancholi P; Vinayak VK; Khuller GK
    Indian J Exp Biol; 1990 Feb; 28(2):127-33. PubMed ID: 1695196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.